An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of RemsimaTM in Patients with Rheumatoid Arthritis

First published 11/02/2015

Last updated 15/02/2019

EU PAS number:

EUPAS8571

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

CT-P13 4 2_RA registry protocol_EU-specific_Ver 2.1 03Jun15_Synopsis for PASS_clean

English (31.86 KB - PDF)View document

Study results

Study report

Other information

Study, other information

01 EULAR 2017_CT-P13 4.2 2Y_Abstract (publication only)

English (185.04 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents